Article · Volume 17, Issue 1 · pp. 89–92

Etoricoxib Induced Toxic Epidermal Necrolysis: A Case Report

Saba Farooqui¹, Zuha Shyma¹, Suha Zulekha¹, Jacintha Martis², Adarsh V V¹

¹Department of Pharmacy Practice, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka, INDIA..
²Department of Dermatology, Father Muller Medical College Hospital, Mangalore, Karnataka, INDIA..

Abstract

Toxic Epidermal Necrolysis (TEN) is a rare and life-threatening skin reaction that can quickly lead to dehydration and infection. TEN is perhaps the most formidable disease encountered by dermatologists, and it remains as puzzling a disorder as it was when described by Lyell. Etoricoxib is a medication that has been associated with TEN. The ideal medical management of TEN should be multidisciplinary and requires early diagnosis and withdrawal of suspected/causative drug(s), supportive care, and specific therapy. Here we present a case of Toxic Epidermal Necrolysis due to Etoricoxib in an immune-compromised patient.

Keywords: Toxic Epidermal Necrolysis; Etoricoxib; Case Report

The full text of this article is available as a PDF. Open the PDF.